Overview
- 5 public-safe observations are available for this inspection.
- 5 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
23 Apr 2026
ISO 13485:2016 Clause 7.3.9
Procedures to control design and development changes not documented
Cited by Yuliana Hernandez-Magana
23 Apr 2026
ISO 13485:2016 Clause 7.4.1
Supplier performance not monitored
Cited by Yuliana Hernandez-Magana
23 Apr 2026
ISO 13485:2016 Clause 7.5.6
Process for production and service provision not validated
Cited by Yuliana Hernandez-Magana
23 Apr 2026
ISO 13485:2016 Clause 8.2.1
Information gathered in feedback process not used as input into risk management
Cited by Yuliana Hernandez-Magana
23 Apr 2026
ISO 13485:2016 Clause 8.2.2
Complaint handling procedures lack required elements
Cited by Yuliana Hernandez-Magana
Inspected site
AMAstura MedicalIrving, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| ISO 13485:2016 Clause 7.3.9 | Cited across public-safe Form 483 observations | 1x |
| ISO 13485:2016 Clause 7.4.1 | Cited across public-safe Form 483 observations | 1x |
| ISO 13485:2016 Clause 7.5.6 | Cited across public-safe Form 483 observations | 1x |
| ISO 13485:2016 Clause 8.2.1 | Cited across public-safe Form 483 observations | 1x |
| ISO 13485:2016 Clause 8.2.2 | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 5 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere